Sawai Group Holdings Co., Ltd.
Tokyo Stock Exchange:4887.T
Sector
Location
Market Cap
USD 1.54 B
Share Price
USD 13.34
Avg Daily Volume
515,693
Change (1 day)
-0.70%
Change (1 year)
-3.94%
Change (YTD)
-2.67%
Sawai Group Holdings Co., Ltd. Operating Cash Flow for the year ending March 31, 2025: USD 185.65 M
Sawai Group Holdings Co., Ltd. Operating Cash Flow is USD 185.65 M for the year ending March 31, 2025, a 21.39% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Sawai Group Holdings Co., Ltd. Operating Cash Flow for the year ending March 31, 2024 was USD 152.95 M, a 55.99% change year over year.
-
Sawai Group Holdings Co., Ltd. Operating Cash Flow for the year ending March 31, 2023 was USD 98.05 M, a -65.21% change year over year.
-
Sawai Group Holdings Co., Ltd. Operating Cash Flow for the year ending March 31, 2022 was USD 281.86 M, a -2.02% change year over year.
-
Sawai Group Holdings Co., Ltd. Operating Cash Flow for the year ending March 31, 2021 was USD 287.67 M, a 2.25% change year over year.
StockViz
Competitors
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.59
2607.HK
-0.01
-0.60%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.27
0874.HK
-0.02
-0.80%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.00
600079.SS
-0.03
-1.05%
MediPal Holdings Corporation
USD 17.49
7459.T
-0.09
-0.48%
Toho Holdings Co., Ltd.
USD 36.46
8129.T
+0.50
1.38%
Sopharma AD
USD 3.45
SPH.WA
-0.01
-0.21%
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Novo Nordisk A/S
USD 50.40
NOVO-B.CO
+2.25
4.67%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.59
2607.HK
-0.01
-0.60%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.27
0874.HK
-0.02
-0.80%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.00
600079.SS
-0.03
-1.05%
MediPal Holdings Corporation
USD 17.49
7459.T
-0.09
-0.48%
Toho Holdings Co., Ltd.
USD 36.46
8129.T
+0.50
1.38%
Sopharma AD
USD 3.45
SPH.WA
-0.01
-0.21%
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Novo Nordisk A/S
USD 50.40
NOVO-B.CO
+2.25
4.67%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%